Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WYETH   ACTAVIS
EQUITY SHARE DATA
    WYETH
Mar-14
ACTAVIS
Dec-18
WYETH/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,06516,037-   
Low Rs55310,758-   
Sales per share (Unadj.) Rs289.53,933.9-  
Earnings per share (Unadj.) Rs38.7-1,267.1-  
Cash flow per share (Unadj.) Rs39.9414.5-  
Dividends per share (Unadj.) Rs145.000-  
Avg Dividend yield %17.90-  
Book value per share (Unadj.) Rs118.516,225.6-  
Shares outstanding (eoy) m22.72332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.83.4 82.1%   
Avg P/E ratio x20.9-10.6 -197.7%  
P/CF ratio (eoy) x20.332.3 62.7%  
Price / Book Value ratio x6.80.8 826.7%  
Dividend payout %374.70-   
Avg Mkt Cap Rs m18,3814,456,026 0.4%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m3590-   
Avg. sales/employee Rs Th077,421.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-24,937.6-  
INCOME DATA
Net Sales Rs m6,5771,308,427 0.5%  
Other income Rs m34725,021 1.4%   
Total revenues Rs m6,9251,333,448 0.5%   
Gross profit Rs m1,02334,287 3.0%  
Depreciation Rs m27559,324 0.0%   
Interest Rs m475,504 0.0%   
Profit before tax Rs m1,339-575,519 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0146,780 0.0%   
Tax Rs m460-7,293 -6.3%   
Profit after tax Rs m879-421,445 -0.2%  
Gross profit margin %15.62.6 593.7%  
Effective tax rate %34.31.3 2,709.0%   
Net profit margin %13.4-32.2 -41.5%  
BALANCE SHEET DATA
Current assets Rs m3,964536,648 0.7%   
Current liabilities Rs m2,081474,737 0.4%   
Net working cap to sales %28.64.7 605.0%  
Current ratio x1.91.1 168.5%  
Inventory Days Days3520 179.2%  
Debtors Days Days27866 418.6%  
Net fixed assets Rs m878148,107 0.6%   
Share capital Rs m2270-   
"Free" reserves Rs m2,4660-   
Net worth Rs m2,6935,396,648 0.0%   
Long term debt Rs m251,900,356 0.0%   
Total assets Rs m4,8428,436,189 0.1%  
Interest coverage x306.0-6.6 -4,620.2%   
Debt to equity ratio x00.4 2.6%  
Sales to assets ratio x1.40.2 875.8%   
Return on assets %18.2-4.1 -445.0%  
Return on equity %32.6-7.8 -418.1%  
Return on capital %49.4-4.8 -1,020.9%  
Exports to sales %0.10-   
Imports to sales %34.70-   
Net fx Rs m-2,2910-   
CASH FLOW
From Operations Rs m1,188467,451 0.3%  
From Investments Rs m287256,804 0.1%  
From Financial Activity Rs m-4,296-802,287 0.5%  
Net Cashflow Rs m-2,821-77,642 3.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 82.88 Rs / USD

Compare WYETH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare WYETH With: SHREE GANESH REMEDIES   MERCURY LAB.  HINDUSTAN BIOSCIE  PFIZER  SUVEN PHARMACEUTICALS  



Today's Market

Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets continued the downtrend as the session progressed and ended the day weak.